Table 2.
Source | HPV types | # of HPV types | # of HPV+ pts (%) | |
---|---|---|---|---|
SCC group | control group | |||
Strumia et al, 1997 | Mucosal | Limited | 6 (60) | 6 (37.5) |
Hsi et al, 1997 | Mucosal | Broad | 15 (21.7) | 1 (3.8) |
Berkhout et al, 2000 | Cutaneous | Broad | 74 (74) | 10 (32.2) |
O’Connor et al, 2001 | Cutaneous | Broad | 18 (85.7) | 5 (17.2) |
Meyer et al, 2001 | Both | Broad | 39 (35.1) | 10 (16.1) |
Caldeira et al, 2003 | Cutaneous | Limited | 12 (46.2) | 4 (9.8) |
Iftner et al 2003 | Both | Broad | 57 (62) | 5 (4.7) |
Gustafsson et al, 2004 (EV type) | Cutaneous | Limited | 1 (3.2) | 5 (16.7) |
Gustafsson et al, 2004 (anogenital type) | Mucosal | Broad | 19 (52.8) | 8 (29.6) |
Zheng et al, 2005 | Both | Broad | 5 (13.2) | 1 (2.1) |
Hazard et al, 2006 | Cutaneous | Limited | 3 (5.8) | 2 (0.7) |
Forslund et al, 2007 | Both | Broad | 21 (25.6) | 42 (12) |
Asgari et al, 2008 | Both | Broad | 46 (54) | 103 (54.2) |
Mackintosh et al, 2009 | Cutaneous | Broad | 34 (56.7) | 6 (33.3) |
Zaravinos et al, 2010 | Both | Broad | 4 (33.3) | 8 (15.1) |
Plasmeijer et al, 2010 | Cutaneous | Broad | 17 (81) | 17 (81) |
Arron et al, 2011 | Cutaneous | Broad | 20 (29.9) | 5 (27.8) |